The platform allows you to achieve exceptional patient engagement, track rich adherence, toxicity and quality of life data, and see and rapidly address clinical deteriorations.

Blue Note Therapeutics is a prescription digital therapeutics company singularly dedicated to helping patients live better. Blue Note is merging deep scientific and clinical expertise with digital and gaming ideas to transform care for seriously ill patients. Working closely with leading medical researchers and patient advocacy organizations, Blue Note is creating clinically validated, FDA-approvable, and prescription-only digital devices to treat the burden of illness. The company was founded in 2018 and is based in San Francisco, California.

Co-developed with hundreds of patients and oncologists, Vinehealth connects patients to their clinical team, helping them to feel confident and in control. The Vinehealth app delivers helpful medication and appointment reminders and reliable, up-to-date information on how to manage treatment and lifestyle issues. Being fully accessible and patient-centric, Vinehealth delivers phenomenal patient engagement and 100% completion rates of QoL measures, such as EQ5D. We never share anyone’s personal data without their permission.

Cancer-related distress, which can be defined as any unpleasant feeling, emotion, or experience that affects a cancer patient’s quality of life or ability to cope with cancer diagnosis and treatment, affects millions of people. Fewer than half of those who experience cancer-related distress have access to the mental health care they need to find relief. Blue Note Therapeutics is working to close this gap.